NCT02813135 2026-01-16
ESMART
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT00463814 2025-11-13
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
AstraZeneca
Phase 1 Active not recruiting
NCT03745989 2023-07-27
MK-8353-014
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT02322749 2016-08-31
A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers
AstraZeneca
Phase 1 Completed
NCT02238782 2016-04-05
A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.
AstraZeneca
Phase 1 Completed